Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands

Viemed Healthcare NASDAQ: VMD outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.

MarketBeat • Aug 29, 2026

Viemed Healthcare Q2 Earnings Call Highlights

Viemed Healthcare NASDAQ: VMD reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.

MarketBeat • Aug 4, 2026

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 5, 2026

Viemed Healthcare Announces Second Quarter 2026 Financial Results

LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026 were $78.1 million, setting a Company record, representing an increase of $15.0 million, or 23.9%, compared with the prior-year quarter and an increase of approximately 3.6% sequentially.

Accesswire • Aug 3, 2026

Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates

Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.

Zacks Investment Research • Aug 3, 2026

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Second Quarter 2026 Earnings Conference Call on Tuesday, August 4, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

Accesswire • Jul 21, 2026

Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?

Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.

The Motley Fool • Jun 10, 2026

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26

Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).

Newsfile Corp • May 12, 2026

Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript

Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 6, 2026

Viemed Healthcare Announces First Quarter 2026 Financial Results

LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.

Accesswire • May 5, 2026